Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05626127

MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma

Conditions: Hilar Cholangiocarcinoma

Sex: All

Ages: 18 Years – 75 Years

Enrollment: 60

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Location: China

Summary

This is a prospective, observational diagnostic study aiming to assess multiparametric MRI-based clinico-radiomics for identifying lymph node metastasis status in hilar cholangiocarcinoma.

Eligibility Criteria

Inclusion Criteria:The patient must sign an informed consent form;Age 18-75 years old, both male and female;ECOG performance status score (PS score) 0-2;Hilar cholangiocarcinoma with resectable tumor lesions;Complete the upper abdomen MRI examination before treatment;Exclusion Criteria:Accompanied with other primary malignant tumors;Patients who have neoadjuvant chemotherapy or other tumor-targeted therapies;Incomplete imaging or medical history data.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05626127). StuddyBuddy aggregates publicly available trial information.